Showing results (1061-1070 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|August 31, 2023
The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort studyMauro Oddo, Fabio S Taccone, Matteo Petrosino, et al.
The Lancet. Neurology|August 26, 2023
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association studyMie Rizig, Sara Bandres-Ciga, Mary B Makarious, et al.
The Lancet. Neurology|August 18, 2023
Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort studyAlissa M D'Gama, Sarah Mulhern, Beth R Sheidley, et al.
The Lancet. Neurology|October 20, 2023
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatmentDavid Adams, Yoshiki Sekijima, Isabel Conceição, et al.
The Lancet. Neurology|July 21, 2023
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trialGeorge Maynard, Ramakrishnan Kannan, Jian Liu, et al.
The Lancet. Neurology|July 21, 2023
Insights into migraine attacks from neuroimagingRoberta Messina, Maria A Rocca, Peter J Goadsby, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
The Lancet. Neurology|June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Michael Benatar, Metin Kurtoglu, et al.
The Lancet. Neurology|June 23, 2023
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trialMichael J R Desborough, Rustam Al-Shahi Salman, Simon J Stanworth, et al.
The Lancet. Neurology|June 23, 2023
Palliative care to support the needs of adults with neurological diseaseBenzi M Kluger, Peter Hudson, Laura C Hanson, et al.
Pageof 199